RAPT Historical Financial Ratios
RAPT Stock | USD 1.42 0.00 0.00% |
RAPT Therapeutics is promptly reporting on over 87 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.98, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 6.97 will help investors to properly organize and evaluate RAPT Therapeutics financial condition quickly.
RAPT |
About RAPT Financial Ratios Analysis
RAPT TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate RAPT Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on RAPT financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across RAPT Therapeutics history.
RAPT Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing RAPT Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on RAPT Therapeutics sales, a figure that is much harder to manipulate than other RAPT Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from RAPT Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into RAPT Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.At this time, RAPT Therapeutics' Net Debt To EBITDA is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.78 in 2025, whereas Book Value Per Share is likely to drop 2.98 in 2025.
2024 | 2025 (projected) | Interest Debt Per Share | 0.11 | 0.1 | Revenue Per Share | 0.054 | 0.0513 |
RAPT Therapeutics fundamentals Correlations
Click cells to compare fundamentals
RAPT Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.